LifeMD, Inc. (LFMD) CEO Justin Schreiber on Q2 2021 Results - Earnings Call Transcript
LifeMD, Inc. (LFMD) delivered earnings and revenue surprises of -13.33% and 3.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
NEW YORK, Aug. 12, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, reported results for the second quarter ended June 30, 2021. All figure compari
Hosted conference call to begin at 4:30 p.m. ET Hosted conference call to begin at 4:30 p.m. ET
Patients Gain Access to Comprehensive Suite of Laboratory and Diagnostic Services at Preferred Pricing, Performed in the Comfort and Convenience of Home Patients Gain Access to Comprehensive Suite of

LifeMD: 'Actual, Hard Numbers' Keep Us Bullish

12:59am, Tuesday, 13'th Jul 2021
LifeMD is a telehealth provider generating strong growth. The company reported Q1 earnings back in May highlighted by impressive momentum in subscriptions revenues while management offered positive gu
These seven meme stocks to buy could be good picks for July as investor interest in these high-risk, high-return plays continues to grow. The post 7 Meme Stocks to Buy for Their ‘To-the-Moon' Potent
Looking for meme stocks to buy? These seven stocks, which are seeing increased price momentum, deserve your attention.
A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare, totaling over $5 billion

LifeMD™ Completes $15M Debt Financing

07:30am, Thursday, 03'rd Jun 2021
Financing significantly bolsters liquidity position to support continued investment in growth of telehealth business Financing significantly bolsters liquidity position to support continued investment
NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that management will present at the Capital Peak Advisor
Cases voluntarily dismissed; company remains focused on growth, increasing access to healthcare via telemedicine Cases voluntarily dismissed; company remains focused on growth, increasing access to he
NEW YORK, May 25, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (NASDAQ: LFMD) a
New York, New York--(Newsfile Corp. - May 22, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against LifeMD, Inc. f/k/a Conversion Labs, Inc. ("LifeMD" or the "Company") (N
SAN DIEGO--(BUSINESS WIRE)-- #LFMDstock--The suit alleges defendants issued false statements concerning LifeMD business and prospects, resulting in its stock trading at inflated prices.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE